The Cushman & Wakefield Life Sciences Group is San Diego County’s most experienced real estate team specializing exclusively in meeting the unique needs of the biotechnology industry. The group regularly negotiates more than 65 percent of all local life sciences transactions, totaling more than $1 billion and 5 million square feet of space -- making it the leading laboratory tenant rep group in the region.
Beginning with Hybritech in 1985, the Cushman & Wakefield Life Sciences Group has been integral to the growth of the San Diego pharmaceutical industry, helping other companies including Biogen Idec, Amylin Pharmaceuticals, Eli Lilly, Gen Probe, Idun Pharmaceuticals, Kalypsys, Chimerix, CovX, MediVas, NovaRx Corp., and Amira Pharmaceuticals find facilities that support their business and growth strategies, location requirements and laboratory needs. The group has also assisted numerous nonprofit research companies with their real estate needs including Sanford | Burnham Institute and The La Jolla Institute for Molecular Medicine. It is also particularly proud to be a co-founder and active member of BIOCOM San Diego.
The Cushman & Wakefield Life Sciences Group takes a leadership role with its clients, presenting every possible real estate alternative in terms that clearly underscore the impact of each decision. The group’s years of brokerage experience are augmented with the analytical and process expertise of other Cushman & Wakefield specialty groups, so clients can make informed decisions based on bottom-line economic and strategic impact.
The team’s multilevel involvement in the local biotechnology community gives it an unmatched depth of knowledge regarding the health and future plans of biopharmaceutical companies. It also gives the team an unparalleled knowledge of every square foot of laboratory space in the county and last offered deal terms. The result: maximum negotiating power and optimum transaction results for its clients.
The Cushman & Wakefield Life Sciences Group is the only San Diego County real estate team dedicated solely to the biopharmaceutical industry. Since its formation in 1982 as a specialized division of Burnham Real Estate, and under the direction of Brent Jacobs, the Cushman & Wakefield Life Sciences Group has become the trusted and reliable resource for pharmaceutical companies, medical research and biotechnology companies.
Backed by a market research department that is nationally known for its state-of-the-art data and analysis, the Cushman & Wakefield Life Sciences Group provides clients with the most accurate and current market information available. Lease and sale analyses are completed thoroughly and quickly, and in accordance to the parameters of each company’s specific needs and requirements. The results are evident in solutions that successfully meet each company’s cost, operations, laboratory and location parameters.
For information, or to request a copy of the most recent Cushman & Wakefield Life Sciences quarterly market report, contact The Cushman & Wakefield Life Sciences Group at 858-452-6500 or visit sdlifesciences.com.
Submitted by Cushman & Wakefield Life Sciences Group